Ozempic and breastfeeding: Experts warn new mothers
Experts weigh in on the safety of using Ozempic while breastfeeding, as concerns rise over potential risks to infants.
Category : Search result: semaglutide
Mounjaro & Ozempic: Weight Loss Breakthrough
New research reveals the surprising long-term benefits of weight loss injections like Mounjaro and Ozempic, offering hope for sustainable obesity management.
Wegovy weight-loss jab in high demand amid US obesity crisis
The US obesity epidemic has led to soaring demand for Wegovy, a weight-loss injection containing semaglutide. Experts warn of supply shortages as prescriptions surge.
Weight loss jabs now available in UK pharmacies
Slimming injections, once restricted to clinical settings, are now accessible in UK pharmacies, revolutionising obesity management with easier access and professional oversight.
Weight loss jabs may slash heart attack risk
Breakthrough research suggests that popular weight loss injections like Wegovy and Ozempic may significantly reduce the risk of cardiovascular events, offering hope for millions.
Weight-loss drugs linked to serious digestive issues
New research reveals that popular weight-loss medications Wegovy and Mounjaro may increase the risk of severe stomach and intestinal problems, including paralysis and pancreatitis.
Page 1 of 1